[News] RSV in 2025–26: immunisation gaps and opportunities

15th Jan, 2026

Respiratory Medicine

The Lancet

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been approved to protect infants from severe RSV disease, multiple countries have generated compelling real-world intervention data, and immunisation eligibility has expanded to include maternal vaccination. As the northern hemisphere enters peak RSV season in December, 2025, public health experts are watching closely.

Published By: The Lancet

Respiratory Medicine

15th Jan, 2026

The Lancet

[Series] Management of prematurity-associated lung disease from infancy through to adulthood

Respiratory Medicine

15th Jan, 2026

The Lancet

[Series] Trajectories of prematurity-associated lung disease: lifelong lung health

Respiratory Medicine

15th Jan, 2026

The Lancet

[Series] Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes

Respiratory Medicine

15th Jan, 2026

The Lancet

[Articles] D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study

Respiratory Medicine

15th Jan, 2026

The Lancet

[Articles] Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial

Respiratory Medicine

15th Jan, 2026

The Lancet

[Spotlight] Nicotine-free generations: a bold policy for public health

Respiratory Medicine

15th Jan, 2026

The Lancet

[News] RSV in 2025–26: immunisation gaps and opportunities

Related Articles

[Series] Management of prematurity-associated lung disease from infancy through to adulthood

[Series] Trajectories of prematurity-associated lung disease: lifelong lung health

[Series] Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes

[Articles] D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study

[Articles] Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial

[Spotlight] Nicotine-free generations: a bold policy for public health

[Spotlight] Sailesh Kotecha—preterm birth respiratory medicine expert

[News] RSV in 2025–26: immunisation gaps and opportunities

Related Articles

[Series] Management of prematurity-associated lung disease from infancy through to adulthood

[Series] Trajectories of prematurity-associated lung disease: lifelong lung health

[Series] Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes

[Articles] D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study

[Articles] Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial

[Spotlight] Nicotine-free generations: a bold policy for public health

[Spotlight] Sailesh Kotecha—preterm birth respiratory medicine expert